A081105 Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

June 30, 2018
https://clinicaltrials.gov/ct2/show/NCT02193282
Cancer - Lung
Principal Investigator: Ding Wang, MD
CANCER, LUNG CANCER, STAGE 1, STAGE 2, STAGE 3, NON-SMALL CELL, NON SMALL CELL
Accepting Participants